IRONWOOD PHARMACEUTICALS, INC. Income Taxes Paid
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Income Taxes Paid of $3.54 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-26
- IRONWOOD PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2011-12-31 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2025 was $3.54M, a 57.86% decline from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2024 was $8.41M, a 15.46% decline from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2023 was $9.95M, a 115.49% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2022 was $4.62M, a 33.69% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|
| 2025-12-31 | $3.54M 10-K · filed 2026-02-26 | ||
| 2024-12-31 | $8.41M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $9.95M 10-K · filed 2025-03-31 | ||
| 2022-12-31 | $4.62M 10-K · filed 2025-03-31 | ||
| 2021-12-31 | $3.45M 10-K · filed 2024-02-16 | ||
| 2020-12-31 | $1.85M 10-K · filed 2023-02-16 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $3.00K 10-K · filed 2014-02-07 | |
| 2011-09-30 | $3.00K 10-Q · filed 2012-11-06 | ||
| 2009-12-31 | -$153.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |